Tom advises clients on global antitrust law, focusing on all aspects of merger control, including multi-jurisdictional risk analysis, deal negotiations, and advocacy before the US Federal Trade Commission and Department of Justice’s Antitrust Division.
He is based in New York, and has worked in our London, Brussels, and Berlin offices.
Tom has experience across various sectors, including technology, pharmaceutical and life sciences, chemicals, and consumer goods.
He has extensive expertise advising on complex global competition cases involving the US, UK, and the EU, having worked on in-depth merger control, mandates relating to competitor collaborations and vertical relationships, abuse of dominance/monopolization, and state aid/subsidy control.
Tom’s experience includes advising:
- Coupa on its $8 billion sale to Thoma Bravo.
- eBay on its acquisition of TCGplayer and its pending acquisition of Certilogo.
- BASF and its Performance Chemicals Division on the carveout sale of its kaolin minerals business to KaMin.
- AstraZeneca on its $39bn acquisition of Alexion.
- Cengage on its all-stock merger with McGraw-Hill Education, Inc.
- Mars on its US$3bn acquisition of Iams and Eukanuba pet food brands from Procter & Gamble.
- LANXESS on the creation of its €2.75bn joint venture with Saudi Aramco in relation to rubber.
- Ferrovial on the sale of interests in Heathrow Airport to China Investment Corporation and Qatar Holding; and Heathrow Airport on its disposal of Stansted Airport.
- Rosneft on numerous strategic joint ventures with ExxonMobil and other oil majors.
3 World Trade Center
175 Greenwich Street, 51st Floor